Pear Therapeutics, Inc. (PEAR) Social Stream



Pear Therapeutics, Inc. (PEAR): $0.03

0.02 (-38.91%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add PEAR to Watchlist
Sign Up

Industry: Medical - Services

Industry

NR

Ranked

#65 of 76

in industry

PEAR THERAPEUTICS INC (PEAR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PEAR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-29 3 $13 $13 $13 $0.118 10916.95%
2022-01-03 4 $13 $12 $12.5 $0.118 10493.22%
2022-03-29 5 $13 $5.5 $10.166 $0.118 8515.25%
2022-05-16 5 $16 $5.5 $11.375 $0.118 9539.83%
2022-05-17 5 $13 $5 $10.5 $0.118 8798.31%
2022-06-06 5 $13 $5 $10.25 $0.118 8586.44%
2022-06-16 6 $12 $5 $9 $0.118 7527.12%
2022-08-12 6 $13 $2 $9 $0.118 7527.12%
2022-08-15 6 $11 $2 $7 $0.118 5832.2%
2022-10-20 6 $11 $2 $6.4 $0.118 5323.73%
2022-11-08 6 $11 $2.3 $6.46 $0.118 5374.58%
2022-11-16 6 $11 $2.8 $6.36 $0.118 5289.83%
2022-12-09 6 $8 $2.8 $5.16 $0.118 4272.88%
2023-03-17 6 $5 $2 $4.25 $0.118 3501.69%
NA 1 $NA $NA $NA $0.118 NA%

The Trend in the Analyst Price Target


PEAR's average price target has moved down $8 over the prior 15 months.

PEAR reports an average of 347.22% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-17 5 13 5 10.250 4.27 140.05%
2022-06-06 6 12 5 9.333 3.40 174.5%
2022-08-12 6 13 2 9.000 2.00 350%
2023-01-12 6 8 2 5.000 1.23 306.5%
2023-03-17 5 5 2 4.250 0.39 989.74%

PEAR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 3 0 0 6

The Trend in the Broker Recommendations


Over the past 26 weeks, PEAR's average broker recommendation rating worsened by 0.34.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • PEAR has a greater upside potential (average analyst target price relative to current price) than 2194.21% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, PEAR THERAPEUTICS INC's average analyst price target is greater than 201.64% of them.
  • PEAR has a higher number of analysts covering the stock than 421.31% of Technology stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, PEAR THERAPEUTICS INC's variance in analysts' estimates is lower than -1375.81% of them.

In the Healthcare industry, SSY, AIH, and BXRX are the three stocks most similar to PEAR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for PEAR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!